BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
Client Focus
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Archives Portfolio
Bryan, Garnier & Co & ING announce the successful completion of BioAlliance Pharma (Eurolist Paris : FR0010095596) EUR 30 m Initial Public Offering
Bryan, Garnier & Co, the European Growth Investment Bank, announces today the successful closing of a Eur 49 million secondary placement of 21 Centrale Partners’ 27.5% stake in SWORD (Euronext: SWP)
Bryan, Garnier & Co, the European Growth investment bank successfully led the the secondary placement of a EUR 13M holding of 21 Investimenti in Stedim, a Euronext-listed company
Bryan, Garnier & Co Leads a EUR 34,9 M follow-on offering of Ordinary Shares with Warrants (ABSA) from Leading International Institutional Investors for Transgene (Eurolist Paris : FR0005175080)
Bryan, Garnier & Co manages a €7m placement for the leading contract research group MAPI Développement with the lead investor Matignon Investissement & Gestion
Bryan, Garnier & Co Leads a EUR 31 million PIPE of Common Stocks from Leading International Institutional Investors for Carrere Group (Euronext : CAR)
Bryan, Garnier & Co, successfully raised a EUR 16 million Private Placement for ASK, the leader in the contactless smart card market
Bryan, Garnier & Co successfully raised a EUR 10.5 million Private Placement for Telisma, an editor of speech recognition software
Bryan, Garnier & Co successfully raised a EUR 8 million Private Placement for esual, a leader in the Executable Internet market
Bryan Garnier & Co successfully syndicates a EUR 7 million P.I.P.E. for CAST, the leading Application Mining software company
1
…
57
58
59
60
Privacy Preference Center
Privacy Preferences